Back to Search
Start Over
[Metabolic bone disease in premature infants and genetic polymorphisms].
- Source :
-
Orvosi hetilap [Orv Hetil] 2007 Oct 14; Vol. 148 (41), pp. 1957-65. - Publication Year :
- 2007
-
Abstract
- Unlabelled: Metabolic bone disease is an important complication among infants very-low-birth-weight (< 1500 g). In adults, osteoporosis has been shown to be associated with polymorphisms of vitamin D receptor, estrogen receptor, and collagen Ialpha1 receptor genes.<br />Aim: The primary goal of the study was to investigate the possible association between metabolic bone disease and the allelic polymorphisms of these three genes.<br />Method: 104 infants very-low-birth-weight were enrolled to the study. Bone formation (serum alkaline phosphatase, osteocalcin) and bone resorption (urinary excretion of calcium and pyridinium crosslink) markers were determined and x-rays of the chest and wrist (together with the distal portions of associated long bones) were obtained.<br />Results: Thirty infants (28,8%) were diagnosed with metabolic bone disease based on high activity of bone formation, bone resorption markers, and positive radiologic signs. Statistically significant correlation between thymine-adenine repeat [(TA) n ] allelic variant of estrogen receptor gene and bone disease was observed. Infants with metabolic bone disease more often carried low number of repeats [(TA) n < 19] [odds ratio (OR): 5.82, 95% confidence interval (CI): 2.26-14.98]. Significantly higher number of repeats [(TA)n > 18] was found more frequently in the control group (OR: 0.20, 95% CI: 0.05-0.82). Furthermore significant interaction between vitamin D receptor and collagen Ialpha1 receptor genotypes ( p = 0.023) was observed. In a forward stepwise logistic regression model, bone disorder of preterms correlated with male gender ( p = 0.001), duration of hospitalization ( p = 0.007), homozygous allelic variants of high number of (TA) n repeats ( p = 0.025) and interaction between vitamin D receptor (Tt) and estrogen receptor (homozygous allelic variants of low number of repeats) genotype ( p = 0.037).<br />Conclusion: The results suggest that the development of metabolic bone disease in infants very-low-birth-weight may be associated with genetic polymorphisms.
- Subjects :
- Adenine
Alkaline Phosphatase blood
Biomarkers blood
Biomarkers urine
Bone Density
Bone Diseases, Metabolic blood
Bone Diseases, Metabolic diagnostic imaging
Bone Diseases, Metabolic urine
Bone Resorption
Calcium Compounds urine
Case-Control Studies
Female
Gene Frequency
Genetic Predisposition to Disease
Humans
Infant, Newborn
Infant, Premature blood
Infant, Premature urine
Infant, Very Low Birth Weight blood
Infant, Very Low Birth Weight urine
Length of Stay
Logistic Models
Male
Microsatellite Repeats
Odds Ratio
Osteocalcin blood
Osteogenesis
Parathyroid Hormone blood
Pyridinium Compounds urine
Radiography
Receptors, Collagen genetics
Thymine
Time Factors
Wrist diagnostic imaging
Bone Diseases, Metabolic genetics
Bone Diseases, Metabolic metabolism
Bone and Bones metabolism
Collagen Type I genetics
Infant, Premature metabolism
Infant, Very Low Birth Weight metabolism
Polymorphism, Genetic
Receptors, Calcitriol genetics
Receptors, Estrogen genetics
Subjects
Details
- Language :
- Hungarian
- ISSN :
- 0030-6002
- Volume :
- 148
- Issue :
- 41
- Database :
- MEDLINE
- Journal :
- Orvosi hetilap
- Publication Type :
- Academic Journal
- Accession number :
- 17921123
- Full Text :
- https://doi.org/10.1556/OH.2007.28179